Vaxart, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Vaxart, Inc. (VXRT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 254.52 thousand shares for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2017-09-01
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2016-09-30 was 254.52K shares, a 30454.98% increase year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2015-09-30 was 833.00 shares, a 99.80% decline year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2015-06-30 was 83.47K shares, a 3.90% decline year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2015-03-31 was 2.83K shares.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2016 was 249.36K shares, a 53.06% decline from fiscal 2015.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2015 was 531.25K shares, a 391.29% increase from fiscal 2014.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2014 was 108.14K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2016-09-30 | 254.52K shares 10-Q · filed 2016-11-08 | |||
| 2016-06-30 | 249.36K shares 10-K · filed 2017-09-01 | |||
| 2015-09-30 | 833.00 shares 10-Q · filed 2015-11-06 | 84.31K shares derived: sum of 2 quarters · filed 2016-09-13 | 87.14K shares derived: sum of 3 quarters · filed 2016-09-13 | 114.18K shares derived: sum of 4 quarters · filed 2016-09-13 |
| 2015-06-30 | 83.47K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | 86.31K shares derived: sum of 2 quarters · filed 2016-09-13 | 113.35K shares derived: sum of 3 quarters · filed 2016-09-13 | 531.25K shares 10-K · filed 2016-09-13 |
| 2015-03-31 | 2.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-08 | 29.87K shares derived: sum of 2 quarters · filed 2015-05-08 | 447.78K shares 10-Q · filed 2015-05-08 | 534.64K shares derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-12-31 | 27.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | 444.94K shares 10-Q · filed 2015-02-06 | 531.81K shares derived: sum of 3 quarters · filed 2015-02-06 | |
| 2014-09-30 | 417.90K shares 10-Q · filed 2014-11-07 | 504.77K shares derived: sum of 2 quarters · filed 2014-11-07 | ||
| 2014-06-30 | 86.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30 | 108.14K shares 10-K · filed 2014-09-30 | ||
| 2014-03-31 | 21.27K shares 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |